# OnCo record breast-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/breast-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "breast-cancer" ;
  schema:name "Breast cancer (all types)"@en ;
  schema:alternateName "TCGA-BRCA"@en, "breast invasive carcinoma (TCGA BRCA cohort)"@en, "Breast carcinoma"@en, "Carcinoma of the breast"@en ;
  schema:description "Breast cancer is not one disease. Which of three receptor patterns the tumour carries decides its treatment: hormone receptor-positive (about 70 percent), HER2-positive (about 15 percent) or triple-negative (about 15 percent). The pages for each type hold the detail; this page holds what they share."@en ;
  schema:url <https://onco.cc/cancers/breast-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Breast_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Breast_cancer>, <https://www.cancer.gov/types/breast> ;
  onco:tag "parent-page" ;
  onco:related <https://onco.cc/cancers/her2-low-metastatic-breast-cancer/>, <https://onco.cc/cancers/inflammatory-breast-cancer/>, <https://onco.cc/cancers/paget-disease-of-the-nipple/>, <https://onco.cc/cancers/phyllodes-tumour/>, <https://onco.cc/cancers/male-breast-cancer/>, <https://onco.cc/cancers/ductal-carcinoma-in-situ/> ;
  onco:pipeline <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/drugs/datopotamab-deruxtecan/>, <https://onco.cc/technologies/oral-serds/> ;
  onco:standardOfCare <https://onco.cc/technologies/mammography/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/cancers/ductal-carcinoma-in-situ/> .